Is oxidative damage in operation in patients with hereditary spastic paraparesis?

Brain and Development

Volumn 32, Issue 2, 2010, Pages 130-136

  Gücüyener, Kivilcim ^a   Guclu Pinarli F ^a   Erbaş, Deniz ^a   Hasanoǧlu, Alev ^a   Serdaroǧlu, Ayşe ^a   Topaloǧlu, Haluk ^b  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Free radicals; Hereditary spastic paraplegia; Nitric oxide; Oxidative damage

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NITRIC OXIDE; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ERYTHROCYTE LEVEL; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SPASTIC PARESIS; VITAMIN BLOOD LEVEL; WALKING DIFFICULTY;

ADOLESCENT; ANTIOXIDANTS; ASCORBIC ACID; CHILD; CHILD, PRESCHOOL; FEMALE; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; INFANT; MALE; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARAPARESIS, SPASTIC; SEVERITY OF ILLNESS INDEX; SPASTIC PARAPLEGIA, HEREDITARY; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 73749086964     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.12.014     Document Type: Article

References (49)

1. Strümpell A. Beiträge zur Pathologie des Rückenmarks. Arch Psychiatr Ner venkr 10 (1880) 676-717
2. Harding A.E. The hereditary ataxias and related disorders (1984), Churchill Livingstone, Edinburgh
3. Harding A.E. Hereditary spastic paraplegias. Semin Neurol 13 (1993) 333-336
4. Reid E. Pure hereditary spastic paraplegia. J Med Genet 34 (1997) 499-503
5. Bundey S. Genetics and neurology (1992), Churchill Livingstone, Edinburgh
6. Hazan J., Lamy C., Melki J., Munnich A., de Recondo J., and Weissenbach J. Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet 5 (1993) 163-167
7. Hazan J., Fontaine B., Bruyn R.P., Lamy C., van Deutekom J.C., Rime C.S., et al. Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet 3 (1994) 1569-1573
8. Fink J.K., Wu C.T., Jones S.M., Sharp G.B., Lange M.M., Lesicki A., et al. Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet 56 (1995) 188-192
9. Hedera P., Rainier S., Alvarado D., Zhao X., Williamson J., Otterud B., et al. Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q. Am J Hum Genet 64 (1999) 563-569
10. Reid E., Dearlove A.M., Rhodes M., and Rubinsztein D.C. A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity. Am J Hum Genet 65 (1999) 757-763
11. Fontaine B., Davoine C.S., Dürr A., Paternot C., Feki I., Weissenbach J., et al. A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet 66 (2000) 702-707
12. Hentati A., Pericak-Vance M.A., Hung W.Y., Belal S., Laing N., Boustany R.M., et al. Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet 3 (1994) 1263-1267
13. De Michele G., De Fusco M., Cavalcanti F., Filla A., Marconi R., Volpe G., et al. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet 63 (1998) 135-139
14. Martínez Murillo F., Kobayashi H., Pegoraro E., Galluzzi G., Creel G., Mariani C., et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology 53 (1999) 50-56
15. Jouet M., Rosenthal A., Armstrong G., MacFarlane J., Stevenson R., Paterson J., et al. X-linked spastic paraplegia (SPG1); MASA syndrome and X linked hydrocephalus result from mutations in the L1 gene. Nat Genet 7 (1994) 402-407
16. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.M., Le Merrer M., Gil R., et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6 (1994) 257-262
17. McDermott C.J., Taylor R.W., Hayes C., Johnson M., Bushby K.M., Turnbull D.M., et al. Investigation of mitochondrial function in hereditary spastic paraparesis. Neuroreport 14 (2003) 485-488
18. Rep M., and Grivell L.A. The role of protein degradation in mitochondrial function and biogenesis. Curr Genet 30 (1996) 367-380
19. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 (1998) 973-983
20. Patel S., and Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol 8 (1998) 65-71
21. Orth M., and Schapira A.H. Mitochondria and degenerative disorders. Am J Med Genet 106 (2001) 27-36
22. Atorino L., Silvestri L., Koppen M., Cassina L., Ballabio A., Marconi R., et al. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163 (2003) 777-787
23. Milano A., Montesano Gesualdi N., Teperino F., Esposito F., Cocozza S., and Ungaro P. Oxidative DNA damage and activation of c-Jun N-terminal kinase pathway in fibroblasts from patients with hereditary spastic paraplegia. Cell Mol Neurobiol 25 (2005) 1245-1254
24. Behan W.M., and Maia M. Strümpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37 (1974) 8-20
25. Piemonte F., Casali C., Carrozzo R., Schägger H., Patrona C., Tessa A., et al. Respiratory chain defects in hereditary spastic paraplegias. Neuromuscul Disord 11 (2001) 565-569
26. Ames B.N., Shigenaga M.K., and Hapen T.M. Oxidants, antioxidants and the degenerative diseases of aging. Natl Acad Sci USA 90 (1993) 7915-7922
27. Gerlach M., Riederer P., and Youdim M.B.H. Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium and excitotoxic amino acids. Adv Neurol 69 (1996) 177-190
28. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 344 (1994) 796-798
29. Coyle J.T., and Puttfercken P. Oxidative stress, glutamate and neuredegenerative disorders. Science 262 (1993) 689-695
30. Topaloǧlu H., Pi{dotless}narli{dotless} F.G., Erdem H., Gücüyener K., Karaduman A., Topçu M., et al. Clinical observations in autosomal recessive spastic paraplegia in childhood and further evidence for genetic heterogeneity. Neuropediatrics 29 (1998) 189-194
31. Mc Kusik V.A. Mendelian inheritance in man. 11th ed. (1994), Johns Hopkins University Press, Baltimore
32. Holley A.E., and Cheesemen K.H. Measuring free radical interactions in vivo. Free Radic Med 49 (1993) 496-505
33. Winterbourn C.C., Hawkins R.E., Brian M., and Carrel R.W. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85 (1975) 337-341
34. Brahman R.S., and Hendrix S.A. Nanograms nitrite and nitrate in enviromental and biological materials by vanadium (III) reduction with chemiluminescence detection. Analytical Chemistry 61 (1989) 2715-2718
35. Rindi G. A rapid colorimetric method for the determination of tocopherol and tocopheryl acetate in plasma. Int Z Vitaminforsch Beih 28 (1958) 225-234 [Special reprint]
36. Dorice M, Czajka-Narins. Methods for the determination of ascorbic acid. In: Norbert W. Tietz. Textbook of clinical chemistry. Philadelphia: W.B. Saunders; 1986. p 960-1.
37. Halliwell B. Reactive oxygen species and the central nervous system. Neurochemistry 59 (1992) 1609-1623
38. Beckman S.J., Ye Y.Z., Chen J., and Conger K.A. The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury. Adv Neurol 71 (1996) 339-350
39. Barrientos A., and Moraes C.T. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem 274 (1999) 16188-16197
40. Facchinetti F., Dawson V.L., and Dawson T.M. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 18 (1998) 667-682
41. Stadtman E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62 (1993) 797-821
42. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 275 (1992) 331-342
43. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85 (1988) 6465-6467
44. Whitmarsh A.J., and Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74 (1996) 589-607
45. Finkel T. Redox-dependent signal transduction. FEBS Lett 476 (2000) 52-54
46. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
47. Cha C.I., Kim J.M., Shin D.H., Kim Y.S., Kim J., Gurney M.E., et al. Reactive astocytes express nitric oxide synthase in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. Neuroreport 9 (1998) 1503-1506
48. Schulz J.B., Mathews R.T., Mugit M.M.K., Browne S.E., and Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64 (1995) 936-939
49. Hall E.D., Oastveen T.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256